GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Net Margin %

BioPharma Credit (LSE:BPCR) Net Margin % : 99.09% (As of Dec. 2022)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. BioPharma Credit's Net Income for the six months ended in Dec. 2022 was $114.1 Mil. BioPharma Credit's Revenue for the six months ended in Dec. 2022 was $115.2 Mil. Therefore, BioPharma Credit's net margin for the quarter that ended in Dec. 2022 was 99.09%.

The historical rank and industry rank for BioPharma Credit's Net Margin % or its related term are showing as below:

LSE:BPCR' s Net Margin % Range Over the Past 10 Years
Min: 89.11   Med: 97.87   Max: 98.95
Current: 98.95


LSE:BPCR's Net Margin % is ranked better than
76.08% of 1668 companies
in the Asset Management industry
Industry Median: 86.62 vs LSE:BPCR: 98.95

BioPharma Credit Net Margin % Historical Data

The historical data trend for BioPharma Credit's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Net Margin % Chart

BioPharma Credit Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial 98.56 97.57 96.58 98.95 98.16

BioPharma Credit Semi-Annual Data
Jun17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 96.33 96.85 98.72 99.09 -

Competitive Comparison of BioPharma Credit's Net Margin %

For the Asset Management subindustry, BioPharma Credit's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioPharma Credit's Net Margin % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's Net Margin % distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's Net Margin % falls into.



BioPharma Credit Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

BioPharma Credit's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=108.45/110.487
=98.16 %

BioPharma Credit's Net Margin for the quarter that ended in Dec. 2022 is calculated as

Net Margin=Net Income (Q: Dec. 2022 )/Revenue (Q: Dec. 2022 )
=114.146/115.194
=99.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioPharma Credit  (LSE:BPCR) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


BioPharma Credit Net Margin % Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


BioPharma Credit (LSE:BPCR) Business Description

Traded in Other Exchanges
N/A
Address
65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit (LSE:BPCR) Headlines

No Headlines